Month: May 2025

Suominen Corporation’s Interim Report on May 7, 2025, at 9:30 a.m. (EEST) Suominen Corporation’s Interim Report for January 1 – March 31, 2025: Navigating a challenging environment KEY FIGURES  1-3/ 1-3/ 1-12/  2025 2024 2024Net sales, EUR million 117.5 113.6 462.3Comparable EBITDA, EUR million 4.1 4.5 17.0Comparable EBITDA, % 3.5 3.9 3.7EBITDA, EUR million 4.1 4.7 17.2EBITDA, % 3.5 4.1 3.7Comparable operating profit, EUR million -0.3 -0.1 -1.4Comparable operating profit, % -0.2 -0.1 -0.3Operating profit, EUR million -0.3 0.1 -1.3Operating profit, % -0.2 0.1 -0.3Profit for the period, EUR million -2.2 -1.0 -5.3Cash flow from operations, EUR million -0.4 -2.2 3.9Cash flow from operations per share, EUR -0.01 -0.04 0.07Earnings per share, basic, EUR -0.04 0.02 -0.09Return on invested capital,...

Company Announcement No 20/20257 May 2025 Sydbank’s Interim Report – Q1 2025 Q1 2025 – highlightsProfit for the period of DKK 645m equals a return on equity of 17.4% p.a. after tax Core income of DKK 1,700m is 8% lower compared to the same period in 2024 Trading income of DKK 64m compared to DKK 89m in the same period in 2024 Costs (core earnings) of DKK 881m compared to DKK 831m in the same period in 2024 Core earnings before impairment of DKK 883m are 20% lower compared to the same period in 2024 Impairment charges for loans and advances etc represent an expense of DKK 35m Bank loans and advances have gone down by DKK 1.2bn, equal to a decrease of 2% compared to year-end 2024 The CET1 ratio stands at 16.3%, equal to a decline of 1.5pp compared to year-end 2024CEO Mark Luscombe comments on the result:It is positive that we have...

OP Corporate Bank plcInterim Report 1 January–31 March 2025Stock Exchange Release 7 May 2025 at 9.00 am EEST OP Corporate Bank plc’s Interim Report 1 January–31 March 2025OP Corporate Bank plc’s operating profit rose to EUR 140 million (112). Total income grew by 10% to EUR 215 million (196). Net interest income, EUR 157 million, remained at the previous year’s level (157). Investment income increased to EUR 24 million (9). Net commissions and fees decreased by 14% to EUR 17 million (19). Other operating income increased to EUR 17 million (11). Impairment loss on receivables decreased to EUR 1 million (12). Total operating expenses increased by 3% to EUR 73 million (71). The cost/income ratio improved to 34% (36). The loan portfolio grew by 1.4% to EUR 28.2 billion (27.8) year on year. The deposit portfolio increased...

Announcement no. 08 – Copenhagen, 7 May 2025 – Agillic A/S ARR from subscriptions increased by 4% in Q1 2025 vs. Q1 2024 due to new clients and stabilisation of churn. Agillic expects growth from both existing clients and new clients in 2025. Total revenue decreased by 1% in Q1 2025 YoY due to lower revenue following last year’s high churn level. Total revenue is expected to increase in 2025 as per 2025 guidance. EBITDA increased by 20% in Q1 2025 vs. Q1 2024. The increase is driven by reduced employee costs following the organisational changes in Q4 2024. Cash flow from operations was DKK 1.9 million in Q1 2025, an increase of DKK 1.9 million YoY. The improved cash flow derives from a positive development in working capital. Key financial and SaaS highlights(DKK million)Income statement Q1 2025 Q1 2024 Change ...

Harvia Plc, Interim report 7 May 2025 at 9:00 a.m. EESTHarvia Q1 2025: Strong profitability – growth in all regions This release is a summary of Harvia Plc’s Interim Report January–March 2025. The complete report is attached to this release as a pdf file. It is also available on Harvia’s website at https://harviagroup.com/. Highlights of the review period January–March 2025:Revenue increased by 22.7% to EUR 52.0 million (42.4). At comparable exchange rates, revenue increased by 21.4% to EUR 51.4 million. Organic revenue growth was 14.1%. Operating profit was EUR 11.9 million (9.9), making up 22.9% (23.3%) of the revenue. Adjusted operating profit was EUR 11.9 million (10.1), making up 22.9% (23.8%) of the revenue. At comparable exchange rates, the adjusted operating profit was EUR 11.9 million (23.1% of the revenue). Operating free...

Wolters Kluwer First-Quarter 2025 Trading Update Alphen aan den Rijn, May 7, 2025 – Wolters Kluwer, a global leader in professional information solutions, software and services, today releases its first-quarter 2025 trading update. HighlightsFull-year 2025 guidance reiterated. First-quarter revenues up 6% in constant currencies and up 5% organically.Recurring revenues (83% of total) up 7% organically; non-recurring revenues down 2% organically. Expert solutions revenues (59%) grew 6% organically. Cloud software revenues (21%) grew 14% organically.First-quarter adjusted operating profit increased 11% at constant currencies. First-quarter adjusted free cash flow increased 5% in constant currencies. Rolling 12-months’-net-debt-to-EBITDA was 1.7x as of March 31, 2025. 2025 share buyback: €286 million of intended up to €1 billion buyback...

OP Financial GroupInterim Report 1 January–31 March 2025Stock Exchange Release 7 May 2025 9.00 am EEST OP Financial Group’s Interim Report for 1 January–31 March 2025: OP Financial Group reports a good first quarter in an uncertain operating environmentOperating profit decreased by 31% to EUR 423 million (618). Net interest income decreased by 11% to EUR 631 million (709). Insurance service result was EUR 2 million (-10) and net commissions and fees were EUR 206 million (205). Income from customer business, that is, net interest income, insurance service result and net commissions and fees, decreased by a total of 7% to EUR 839 million (904). Impairment loss on receivables reversed came to EUR 24 million (-39), representing -0.10% of the loan and guarantee portfolio (0.15). Investment income decreased by 88% to EUR 19 million...

7 May 2025 –  Financial report for the period 1 January 2025 to 31 March 2025                                                                                                                                                                              Operating profit increased by 22% in Danish kroner and by 20% at constant exchange rates (CER) to DKK 38.8 billion. Sales in US Operations increased by 20% in Danish kroner (17% at CER). Sales in International Operations increased by 18% in Danish kroner (19% at CER). Sales within Diabetes and Obesity care increased by 21% in Danish kroner to DKK 73.5 billion (19% at CER), mainly driven by Obesity care growth of 67% in Danish kroner to DKK 18.4 billion (65% at CER) and GLP-1 diabetes sales growing 13% in Danish kroner (11% at CER) and. Rare disease sales increased by 5% measured in...